Pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz Syndrome)

Journal of the Neurological Sciences

Volumn 207, Issue 1-2, 2003, Pages 106-107

  Hayflick, Susan J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS ION; PANTOTHENATE KINASE;

AUTOSOMAL RECESSIVE DISORDER; BASAL GANGLION; CERULOPLASMIN BLOOD LEVEL; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HUMAN; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PRIORITY JOURNAL;

ANIMALS; HALLERVORDEN-SPATZ SYNDROME; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 12244309505     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00433-1     Document Type: Conference Paper

References (2)

1. Zhou B., Westaway S.K., Levinson B.et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics. 28:2001;345-349.
2. Coryell J., Hayflick S. Pantothenate Kinase-Associated Neurodegeneration. GeneReviews: Genetic disease online Reviews at GeneTests-GeneClinics [database online]. 2002;University of Washington, Seattle, http://www.geneclinics.org.